HPV Vaccination Behavior, Vaccine Preference, and Health Beliefs in Chinese Female Health Care Workers: A Nationwide Cross-Sectional Study.

Chinese female health care workers health belief model human papillomavirus vaccine vaccination behavior vaccine preference

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 08 07 2023
revised: 08 08 2023
accepted: 12 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Human papillomavirus (HPV) vaccination has been proven to be the most effective method to prevent cervical cancer. This study aimed to determine the HPV vaccination behavior and preference in Chinese female health care workers. A nationwide cross-sectional study was performed to recruit 15,967 respondents aged 18-45 years from 31 provinces in China's mainland in 2021. Of them, 30.0% have been vaccinated or have made an appointment. Regardless of actual vaccination status, respondents mostly preferred the 9-valent HPV vaccine (58.6%), followed by 4-valent (15.6%) and 2-valent vaccines (3.1%); additionally, 17.9% did not have a preference. Moreover, health beliefs on HPV and HPV vaccination were measured using a health belief model (HBM) analysis. Six HBM constructs differed significantly by HPV vaccination status. Higher levels of perceived susceptibility (beta = 0.074), perceived benefit (beta = 0.072), self-efficacy (beta = 0.304), and cues to action (beta = 0.039) scales were significantly associated with increasing HPV vaccine uptake. In contrast, perceived severity (beta = -0.019) and perceived barriers (beta = -0.089) were negative factors. In conclusion, HPV vaccine uptake is high in Chinese female health care workers. HBM constructs may be effective in facilitating the improvement and delivery of targeted intervention programs to increase HPV vaccine uptake.

Identifiants

pubmed: 37631935
pii: vaccines11081367
doi: 10.3390/vaccines11081367
pmc: PMC10458891
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Environ Res Public Health. 2021 Jul 01;18(13):
pubmed: 34280979
Vaccine. 2021 Jan 3;39(1):35-44
pubmed: 33243631
J Behav Med. 2016 Jun;39(3):429-40
pubmed: 26782668
Adolesc Health Med Ther. 2014 Jun 06;5:101-14
pubmed: 24966710
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Epidemiol Infect. 2017 Jul;145(9):1786-1796
pubmed: 28434418
Ann Behav Med. 2012 Oct;44(2):171-80
pubmed: 22547155
Nat Biotechnol. 2013 Jul;31(7):590-1
pubmed: 23839139
Cancer Lett. 2017 Aug 10;401:63-71
pubmed: 28476483
Vaccines (Basel). 2021 Oct 20;9(11):
pubmed: 34835149
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2155-2163
pubmed: 30139219
J Med Internet Res. 2021 Sep 6;23(9):e29329
pubmed: 34280115
Public Health. 2014 Mar;128(3):268-73
pubmed: 24529635
Clin Epidemiol Glob Health. 2021 Jan-Mar;9:41-46
pubmed: 33521389
BMC Public Health. 2021 Apr 26;21(1):804
pubmed: 33902501
Lancet Infect Dis. 2016 Dec;16(12):1322-1323
pubmed: 27998583
Res Theory Nurs Pract. 2020 Nov 1;34(4):340-357
pubmed: 33199407
J Cancer Educ. 2021 Feb;36(1):168-177
pubmed: 31502236
Appl Psychol Health Well Being. 2021 May;13(2):469-484
pubmed: 33634930
Int J Gynaecol Obstet. 2012 Sep;118(3):247-50
pubmed: 22727336
Vaccine. 2020 Dec 14;38(52):8310-8317
pubmed: 33223307
Am J Health Promot. 2023 May;37(4):488-498
pubmed: 36306535
PLoS One. 2018 Dec 6;13(12):e0208402
pubmed: 30521602
Vaccine. 2021 Feb 12;39(7):1148-1156
pubmed: 33461834
Infect Dis Clin North Am. 2013 Dec;27(4):765-78
pubmed: 24275269

Auteurs

Xiaoping Shao (X)

Department of Intensive Care Medicine, The Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China.

Xinyue Lu (X)

Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, Fudan University School of Public Health, Shanghai 200032, China.

Weiyu Zhou (W)

Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, Fudan University School of Public Health, Shanghai 200032, China.

Weifeng Huang (W)

Department of Intensive Care Medicine, The Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China.

Yihan Lu (Y)

Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, Fudan University School of Public Health, Shanghai 200032, China.

Classifications MeSH